Butaclamol
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number | 36504-93-5 |
PubChem (CID) | 37459 |
IUPHAR/BPS | 62 |
ChemSpider | 34364 |
UNII | A7A2802VNL Y |
ChEBI | CHEBI:73298 Y |
ChEMBL | CHEMBL479587 Y |
Chemical and physical data | |
Formula | C25H31NO |
Molar mass | 361.52 g/mol |
3D model (Jmol) | Interactive image |
|
Butaclamol (AY-23,028) is an antipsychotic which was never marketed.[1] Sold as the hydrochloride salt for use in research, the compound acts as a dopamine receptor antagonist.[2]
Chemistry
pKa = 7.15 (uncorrected for ionic strength)[3]
See also
References
- ↑ Buckingham, J. Dictionary of organic compounds - Google Books. ISBN 9780412540905.
- ↑ http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=D033%7CSIGMA&N25=0&QS=ON&F=SPEC
- ↑ F. A. Chrzanowski, B. A. McGrogan, B. E. Maryanoff (1985). "The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors." J. Med. Chem. 28 399-400.
Classes |
|
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
This article is issued from Wikipedia - version of the 9/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.